Project Grant HT94252510024
Award Date
6/1/25
Completion Date
5/31/29
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $1,188,750.00 to Temple University-Of The Commonwealth System Of Higher Education to identify therapeutic peptide drugs for regenerating visual pathways. The 3-year award, effective from September 15, 2024 to September 14, 2027, supports advanced biomedical research focused on transforming healthcare for military service members and the broader...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) provides $2,495,419.00 to The Trustees of the University of Pennsylvania (Penn) to develop a blood-based biomarker for detecting blood-brain barrier dysfunction in traumatic brain injury. The project aims to transform healthcare for service members and the public by developing innovative medical solutions for the battlefield through July 1, 2023 to June 30, 2027....
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $4,343,333.00 to Drexel University to develop and validate clinical outcome measures, study the natural history, and explore interventions for mild traumatic brain injury-related vision disorders. The project will be performed in Philadelphia, PA and is scheduled for completion by Sep 29, 2028. This research aims to transform healthcare for...
This federal Project Grant award of $1,585,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Temple University to target lymphatic chemokine signaling and promote lymphangiogenesis for the treatment of lymphedema. The 4-year award, starting on March 1, 2025 and ending on February 28, 2029, will enable the university to conduct advanced biomedical research focused on transforming healthcare for military...
This Project Grant award in the amount of $679,085.00 was issued by the Defense Health Agency, a component of the Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University, to investigate the role of tumor-associated sensory neurons in breast cancer invasion and metastasis. The award period runs from January 15, 2024...
The U.S. Defense Health Agency awarded a $792,500.00 Project Grant to Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University-Of The Commonwealth System Of Higher Educa and doing business as Temple University, for the purpose of "AN EFFECTIVE STRATEGY TO PROMOTE AXON REGENERATION AND FUNCTIONAL RECOVERY AFTER SPINAL CORD INJURY". The Project Grant is funded through the U.S. Military Medical Research and Development program (CFDA 12.420),...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $683,442 Project Grant on September 1, 2023 to The Trustees of the University of Pennsylvania to conduct a 3-year study on "Trajectories of Neuroimaging and Blood-Based Biomarkers After Remote Traumatic Brain Injury and Associations with Dementia Risk." The University of Pennsylvania will collaborate with Mayo Clinic on a sub-award to investigate longitudinal changes in brain...
The U.S. Defense Health Agency awarded a $546,681 project grant to Temple University to fund the "PROJECT IMPACT-AUTISM: INTERNET-BASED MODEL FOR PARAEDUCATORS TO AUGMENT COMPREHENSIVE TREATMENT FOR AUTISTIC LEARNERS" program under the Military Medical Research and Development (CFDA 12.420) federal grant program. This 3-year grant, effective September 1, 2025 through August 31, 2028, supports Temple University's research and development of an internet-based training model for...
Temple University-Of The Commonwealth System Of Higher Education received a $315,618 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 1, 2023 through May 31, 2025 examining the role of exosomes on the alveolar epithelium in idiopathic pulmonary fibrosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
The Defense Health Agency awarded a $1,973,398 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Azevan Pharmaceuticals Inc. in Bethlehem, PA. The grant supports the development of a new drug to prevent the effects of mild traumatic brain injury (TBI) or concussion. The research project will be conducted over a 2-year period from June 2024 to June 2026. The goal is to advance the development of an innovative medical solution to address this critical...